✦ LIBER ✦

355 Limited Benefit of Biochemical Response to Combination Therapy with Interferon and Ribavirin for Patients with Recurrent Hepatitis C After Living-Donor Liver Transplantation

✍ Scribed by Ueda, Yoshihide; Takada, Yasutsugu; Haga, Hironori; Nabeshima, Motoshige; Marusawa, Hiroyuki; Ito, Takashi; Egawa, Hiroto; Tanaka, Koichi; Uemoto, Shinji; Chiba, Tsutomu

Book ID: 123433254
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 116 KB
Volume: 134
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)63561-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of double-filtration plasmaphere

Effects of double-filtration plasmapheresis combined with interferon plus ribavirin for recurrent hepatitis C after living donor liver transplantation

✍ Yasutsugu Takada; Takashi Ito; Yoshihide Ueda; Hironori Haga; Hiroto Egawa; Koic 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Response rates to interferon and ribavirin treatment for recipients with recurrent hepatitis C virus (HCV) infection are suboptimal, particularly for those with genotype 1b and high viral load. The present study evaluated the effects of combining double-filtration plasmapheresis (DFPP) with pharmaco

Interleukin-28B single nucleotide polymo

Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation

✍ Tomokazu Kawaoka; Shoichi Takahashi; Shintaro Takaki; Akira Hiramatsu; Koji Waki 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB

Clinical features of biochemical cholest

Clinical features of biochemical cholestasis in patients with recurrent hepatitis C after living-donor liver transplantation

✍ Y. Ueda; Y. Takada; H. Marusawa; H. Haga; T. Sato; Y. Tanaka; H. Egawa; S. Uemot 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

Interferon-lambda4 genetic polymorphism

Interferon-lambda4 genetic polymorphism is associated with the therapy response for hepatitis C virus recurrence after a living donor liver transplant

✍ Konishi, H.; Motomura, T.; Matsumoto, Y.; Harimoto, N.; Ikegami, T.; Yoshizumi, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB

Predictors of virologic response in comb

Predictors of virologic response in combination therapy with interferon (IFN) alfa 2B plus ribavirin of recurrent hepatitis C after liver transplantation (LT)

✍ B. Lavezzo; A. Franchello; A. Smedile; D. Cocchis; E. David; A. Barbui; A. Ottob 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Combination therapy/prophylaxis with int

Combination therapy/prophylaxis with interferon and ribavirin for recurrent hepatitis C after liver transplantation: long-term effects on graft function and morphology

✍ A Kornberg; M Hommann; A Tannapfel; T.h Grube; U Schotte; J Scheele 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 48 KB